Skip to main content
. 2023 Aug 3;14:1201973. doi: 10.3389/fimmu.2023.1201973

Figure 6.

Figure 6

Evaluation of the efficacy of the BoHV-4 vectored PRRSV vaccine candidate. The ability of BoHV-4-M-NSP5 immunization to confer protection was assessed following challenge infection of pigs with the divergent strain LT-3 (Study 2). PRRSV loads in the blood (A) and lungs (B) were inferred from RT-qPCR analysis of serum and BALF samples, respectively, and gross lung lesions (C) and lung histopathology (D; Study 2 scores for 10 days post-challenge) were scored. Mean data ± SD are shown for (A), whereas for (B–D), data points represent individual pigs, with the mean indicated by a horizontal line.